Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cardinal Health (NY: CAH ) 111.98 +1.63 (+1.48%) Official Closing Price Updated: 4:10 PM EDT, Oct 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Cardinal Health < Previous 1 2 ... 6 7 8 9 10 11 12 13 Next > Don't Wait for Your Dividends. Here's How You Can Collect Cash Every Month. March 22, 2023 These stocks all pay more than what you'd get with the average stock on the S&P 500. Via The Motley Fool The Latest Analyst Ratings for Cardinal Health March 22, 2023 Via Benzinga 3 Inflation-Resistant Businesses That Recently Raised Guidance March 21, 2023 These stocks can be relatively safe places to invest in if you're worried about inflation. Via The Motley Fool 7 Stocks Set to Soar When the Market Recovers March 16, 2023 Daring contrarians can bid up the danger with these intriguing market ideas. Via InvestorPlace Healthcare Stocks With at Least 30 Years of Dividend Increases March 14, 2023 Among the many industry sectors to invest in, healthcare can be one of the most stable, especially regarding the dividend yield. Via MarketBeat Cardinal Health's Earnings Outlook February 01, 2023 Via Benzinga 7 Analysts Have This to Say About Cardinal Health January 31, 2023 Via Benzinga The Latest Analyst Ratings for Cardinal Health January 06, 2023 Via Benzinga Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company? March 01, 2023 By David Willey, Benzinga Via TheNewswire.com Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company? March 01, 2023 Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company? Via News Direct Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company? March 01, 2023 The medical device and supply manufacturing industry is focused on the design and production of medical instruments and devices. Via Benzinga This Stock Could Fill Your Pockets for Years to Come March 01, 2023 $273 billion in sales from a company you've probably never heard of. Via The Motley Fool 3 Great Value Stocks To Buy Now For Steady Long-Term Growth February 18, 2023 We explore three highly-ranked value stocks with resilient businesses—CAH, GPK and BJ—that investors might want to consider buying amid lingering inflation. Via Talk Markets RxLive and Cardinal Health’s Outcomes collaborate to enhance connectivity between providers across transitions of care February 16, 2023 Collaboration connects My.RxLive tool to the OutcomesOne™ platform to improve communication and drive better patient outcomes, reducing readmission and unnecessary cost. From RxLive Via GlobeNewswire Is This Warren Buffett Stock a Buy for Dividend Growth Investors? February 16, 2023 This Buffett-backed business leads the medical distribution industry. Via The Motley Fool With COVID-19 Having Placed A Sharp Focus On Syringes, This Innovator Looks Back At A Year Of Successes Since Their 2022 IPO February 15, 2023 Medical device company Sharps Technology Inc. (NASDAQ: STSS) is taking stock as it approaches one year since its initial public offering (IPO). Since its IPO, the company has taken major strides in... Via Benzinga Battleground Stocks: 3 Heavily Shorted Meme Stocks to Watch February 14, 2023 Heavily shorted meme stocks are often considered high-risk investments due to their volatility and potential for rapid gains or losses. Via InvestorPlace Palantir Q4 Earnings Preview: Will The Data Software Company Deliver On CEO Expectations For A 'Strong Finish To The Year'? February 13, 2023 Palantir Technologies Inc (NYSE: PLTR) is set to report fourth-quarter earnings results after the bell. The stock is up approximately 18% since the start of the year, but it's still down more than 40%... Via Benzinga Why Palantir, Twilio, and HubSpot Each Surged Over 20% in January February 07, 2023 Beaten-down enterprise software stocks got a relief rally in January. But will the good times last? Via The Motley Fool Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2023 February 03, 2023 Via Benzinga Nasdaq Futures Fly As Meta Keeps Tech Earnings' Buoyancy Intact: Will Apple, Amazon, Alphabet Toe In Line? February 02, 2023 The index futures point to a mixed opening on Thursday, as tech earnings continue to be encouraging. Via Benzinga Can Market Sustain Upward Momentum In Tech-Heavy Earnings Week? Apple, Amazon, AMD, Alphabet, Ford Among Key Quarterly Reports To Watch January 29, 2023 With a full week of earnings behind us, it’s time to take stock of the fourth-quarter reporting season so far. Overall, the news flow has been mixed, although tech earnings have grossly disappointed. Via Benzinga Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products January 17, 2023 By David Willey, Benzinga Via TheNewswire.com Topics Economy Exposures Supply Chain Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products January 17, 2023 Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products Via News Direct Topics Economy Exposures Supply Chain Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products January 17, 2023 Sharps Technology, Inc. (NASDAQ: STSS) recently announced that the Company will be commercializing cutting-edge prefillable syringe system products to provide new solutions to customers in the... Via Benzinga Sharps Technology Is Injecting A Better Solution Into The Healthcare Syringe Industry January 09, 2023 Medical device company Sharps Technology, Inc. (NASDAQ: STSS) is closing out a successful year after its April initial public offering (IPO) on the NASDAQ market. The company focuses on the development... Via Benzinga Global Drug Delivery Systems Market Size Projected to Reach $71.75 Billion By 2029 January 12, 2023 EQNX::TICKER_START (NASDAQ:STSS),(NYSE:BDX),(NYSE:CAH),(NYSE:NVO),(OTCPK:TRUMY),(NASDAQ:STSSW) EQNX::TICKER_END Via FinancialNewsMedia Exposures COVID-19 Buying These 2 Stocks Is a Good Way to Hedge Against a Market Crash January 07, 2023 If the tide runs out, you won't be caught swimming naked with these two stocks in your portfolio. Via The Motley Fool 2 Dividend Aristocrat Stocks To Buy And Never Sell January 06, 2023 A dividend aristocrat is a stock that is a member of the S&P500 that has raised dividend payments for at least 25 consecutive years. This filter alone is an effective way to identify companies with... Via Talk Markets 5 Stocks In S&P 500 ETF With 40% Gains In 2022 January 03, 2023 Despite the decline, some of the stocks in SPY’s portfolio have risen more than 40%. Via Talk Markets < Previous 1 2 ... 6 7 8 9 10 11 12 13 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.